On Thursday, United States health officials said that they recommended Moderna or Pfizer coronavirus vaccines instead of the Johnson & Johnson (J&J) dose that can cause rare but severe blood clots. Advisers to the CDC (Centers for Disease and Prevention) said that the mysterious clotting issue caused nine confirmed deaths after Johnson & Johnson vaccination shots – while the Moderna and Pfizer vaccines do not come with that risk and appear more efficient.
Furthermore, the CDC’s director Dr. Rochelle Walensky, endorsed the advice of the panel as it recommended the exceptional move of giving preference to the Moderna and Pfizer vaccines. So far, the United States treated all three Coronavirus vaccines available to the American nationals as an equal option since comprehensive research found they all offered adequate protection and limited initial supplies.
A CDC panel says people shouldn’t get the J&J Covid-19 vaccine when Pfizer and Moderna shots are available. NBC’s @DrJohnTorres explains: “That does not take Johnson & Johnson off the table, because if that’s the only one you can get, they’re saying go ahead and get that.” pic.twitter.com/8t9GFIcdeJ
— Hallie Jackson NOW (@HallieOnNBC) December 17, 2021
The Johnson & Johnson vaccine primarily approved the single-dose option that could be specifically important for hard-to-reach groups such as homeless individuals who might not receive the essential second shot of the Moderna and Pfizer options. However, the CDC advisers said that during yesterday’s meeting that it was time to accept excessive change since inoculation started rolling out one year ago.
16 million Americans got the Johnson & Johnson Shot
Over two hundred million Americans received full vaccination shots, including around sixteen million who received the J&J vaccine doses. Recent statistics from exceptional safety tracking of all those vaccinations influenced the expert panel that while the blood clots linked with the Johnson & Johnson vaccine remain very rare, they are still occurring in all types of patients.
CDC advisers decided to prefer the safer Moderna and Pfizer vaccines unanimously. However, they said that the J&J vaccine division still should be available if somebody really wants it – or has a severe allergy to the other options. The CDC adviser, Dr. Beth Bell of the University of Washington, said that he wouldn’t recommend the J&J vaccine to his family members, but some people may choose that shot.
Initially, the clotting issue was spotted last spring, with the Johnson & Johnson does in the United States and with a similar AstraZeneca vaccine used in other nations. Ultimately American regulators decided the one-and-done Johnson & Johnson vaccine benefits overshadowed what was considered a sporadic risk. Likewise, European health regulators continued to endorse the two-dose AstraZeneca Coronavirus vaccine because initial reports were mostly in younger women, some nations issued age restrictions.
Rogue Immune Reaction to the Johnson & Johnson and AstraZeneca Vaccines
Coronavirus also causes deadly blood clots. But the type of vaccine-linked clots is different because of a rouge immune response to the AstraZeneca and Johnson & Johnson vaccines because of the chemical manufacturing formula. It forms in rare body parts, like veins that drain blood from the brain, and in patients who also develop low platelets that form blood clots. The following are some symptoms of the unusual clots after receiving the J&J vaccination shot:
- Dubbed thrombosis with thrombocytopenia syndrome
- Severe headaches a week or two
- Abdominal pain
The Food and Drug Administration said that it is still scarce; the FDA told health care providers this week that more clotting cases occurred after Johnson & Johnson vaccinations since the spring. Most of the cases occurred in women ages thirty to forty-nine – around once for every one hundred thousand shots administered. The CDC’s doctor Isaac See said Thursday that the government confirmed overall fifty-four blood clot cases, seventeen in men and thirty-seven in women, along with nine deaths that included two men. He also said that two patients are also critical to death.
The Pros and Cons of COVID-19 Vaccines
The CDC decides how COVID-19 vaccines should be used in the United States, and its health advisers called the continuous deaths troubling. However, in comparing the pros and cons of all COVID-19 vaccines, the panelists of the agency agreed that side effects from the Moderna and Pfizer vaccines were not as serious – and that vaccine supplies now are plentiful.
For the recipients of Johnson & Johnson, the health officials recommended a booster at least two months after the vaccination. Moreover, the United States health officials previously approved a mixing and match strategy for vaccines for booster doses. Many nations, including Canada, already have guidelines that give preference to Moderna and Pfizer vaccines.